Login
Get Started

Understanding PT-141 (Bremelanotide)

Who can benefit from PT-141?

PT-141  may be particularly beneficial for women experiencing low libido or reduced sexual interest, desire discrepancy with their partner (where you want to want sex more), decreased arousal despite physical health, stress or anxiety affecting sexual desire, difficulty getting “in the mood,” hormonal changes affecting libido (like postpartum or perimenopause), or those who want to enhance the psychological and emotional aspects of sexual experiences. It can be used by women of all ages who are experiencing challenges with sexual desire.

Androgenetic alopecia (pattern baldness) is caused by genetic sensitivity to DHT (dihydrotestosterone), a hormone created when the enzyme alpha reductase converts testosterone to DHT. In genetically susceptible individuals, DHT binds to receptors in hair follicles, causing follicular miniaturization where follicles progressively shrink, produce thinner and shorter hairs, have shorter growth cycles, and eventually become dormant.

In men, this typically presents as receding hairline starting at temples, thinning at the crown, and progressive loss following predictable patterns (Norwood scale). In women, it presents as diffuse thinning across the top of the scalp, widening part line, generally preserved hairline, and less complete baldness than men (Ludwig scale).

The process is gradual over years or decades, influenced by genetics (from both parents, not just maternal grandfather), hormones (DHT sensitivity), age (typically starts but can begin earlier), and other factors like stress, nutrition, medications, and underlying health conditions. Understanding the cause is crucial because it explains why effective treatments must address DHT and follicular stimulation.

Androgenetic alopecia (pattern baldness) is caused by genetic sensitivity to DHT (dihydrotestosterone), a hormone created when the enzyme alpha reductase converts testosterone to DHT. In genetically susceptible individuals, DHT binds to receptors in hair follicles, causing follicular miniaturization where follicles progressively shrink, produce thinner and shorter hairs, have shorter growth cycles, and eventually become dormant.

In men, this typically presents as receding hairline starting at temples, thinning at the crown, and progressive loss following predictable patterns (Norwood scale). In women, it presents as diffuse thinning across the top of the scalp, widening part line, generally preserved hairline, and less complete baldness than men (Ludwig scale).

The process is gradual over years or decades, influenced by genetics (from both parents, not just maternal grandfather), hormones (DHT sensitivity), age (typically starts but can begin earlier), and other factors like stress, nutrition, medications, and underlying health conditions. Understanding the cause is crucial because it explains why effective treatments must address DHT and follicular stimulation.

Androgenetic alopecia (pattern baldness) is caused by genetic sensitivity to DHT (dihydrotestosterone), a hormone created when the enzyme alpha reductase converts testosterone to DHT. In genetically susceptible individuals, DHT binds to receptors in hair follicles, causing follicular miniaturization where follicles progressively shrink, produce thinner and shorter hairs, have shorter growth cycles, and eventually become dormant.

In men, this typically presents as receding hairline starting at temples, thinning at the crown, and progressive loss following predictable patterns (Norwood scale). In women, it presents as diffuse thinning across the top of the scalp, widening part line, generally preserved hairline, and less complete baldness than men (Ludwig scale).

The process is gradual over years or decades, influenced by genetics (from both parents, not just maternal grandfather), hormones (DHT sensitivity), age (typically starts but can begin earlier), and other factors like stress, nutrition, medications, and underlying health conditions. Understanding the cause is crucial because it explains why effective treatments must address DHT and follicular stimulation.

Androgenetic alopecia (pattern baldness) is caused by genetic sensitivity to DHT (dihydrotestosterone), a hormone created when the enzyme alpha reductase converts testosterone to DHT. In genetically susceptible individuals, DHT binds to receptors in hair follicles, causing follicular miniaturization where follicles progressively shrink, produce thinner and shorter hairs, have shorter growth cycles, and eventually become dormant.

In men, this typically presents as receding hairline starting at temples, thinning at the crown, and progressive loss following predictable patterns (Norwood scale). In women, it presents as diffuse thinning across the top of the scalp, widening part line, generally preserved hairline, and less complete baldness than men (Ludwig scale).

The process is gradual over years or decades, influenced by genetics (from both parents, not just maternal grandfather), hormones (DHT sensitivity), age (typically starts but can begin earlier), and other factors like stress, nutrition, medications, and underlying health conditions. Understanding the cause is crucial because it explains why effective treatments must address DHT and follicular stimulation.

Androgenetic alopecia (pattern baldness) is caused by genetic sensitivity to DHT (dihydrotestosterone), a hormone created when the enzyme alpha reductase converts testosterone to DHT. In genetically susceptible individuals, DHT binds to receptors in hair follicles, causing follicular miniaturization where follicles progressively shrink, produce thinner and shorter hairs, have shorter growth cycles, and eventually become dormant.

In men, this typically presents as receding hairline starting at temples, thinning at the crown, and progressive loss following predictable patterns (Norwood scale). In women, it presents as diffuse thinning across the top of the scalp, widening part line, generally preserved hairline, and less complete baldness than men (Ludwig scale).

The process is gradual over years or decades, influenced by genetics (from both parents, not just maternal grandfather), hormones (DHT sensitivity), age (typically starts but can begin earlier), and other factors like stress, nutrition, medications, and underlying health conditions. Understanding the cause is crucial because it explains why effective treatments must address DHT and follicular stimulation.

Androgenetic alopecia (pattern baldness) is caused by genetic sensitivity to DHT (dihydrotestosterone), a hormone created when the enzyme alpha reductase converts testosterone to DHT. In genetically susceptible individuals, DHT binds to receptors in hair follicles, causing follicular miniaturization where follicles progressively shrink, produce thinner and shorter hairs, have shorter growth cycles, and eventually become dormant.

In men, this typically presents as receding hairline starting at temples, thinning at the crown, and progressive loss following predictable patterns (Norwood scale). In women, it presents as diffuse thinning across the top of the scalp, widening part line, generally preserved hairline, and less complete baldness than men (Ludwig scale).

The process is gradual over years or decades, influenced by genetics (from both parents, not just maternal grandfather), hormones (DHT sensitivity), age (typically starts but can begin earlier), and other factors like stress, nutrition, medications, and underlying health conditions. Understanding the cause is crucial because it explains why effective treatments must address DHT and follicular stimulation.

Androgenetic alopecia (pattern baldness) is caused by genetic sensitivity to DHT (dihydrotestosterone), a hormone created when the enzyme alpha reductase converts testosterone to DHT. In genetically susceptible individuals, DHT binds to receptors in hair follicles, causing follicular miniaturization where follicles progressively shrink, produce thinner and shorter hairs, have shorter growth cycles, and eventually become dormant.

In men, this typically presents as receding hairline starting at temples, thinning at the crown, and progressive loss following predictable patterns (Norwood scale). In women, it presents as diffuse thinning across the top of the scalp, widening part line, generally preserved hairline, and less complete baldness than men (Ludwig scale).

The process is gradual over years or decades, influenced by genetics (from both parents, not just maternal grandfather), hormones (DHT sensitivity), age (typically starts but can begin earlier), and other factors like stress, nutrition, medications, and underlying health conditions. Understanding the cause is crucial because it explains why effective treatments must address DHT and follicular stimulation.

Understanding
Arousal Cream

How do I apply the arousal cream?

Sermorelin is a bioidentical synthetic peptide that consists of the first 29 amino acids of growth hormone releasing hormone (GHRH). Your pituitary gland naturally produces GHRH to signal the release of growth hormone. As we age, both GHRH and growth hormone levels decline, contributing to many signs of aging. Sermorelin mimics natural GHRH, restoring the signal that tells your pituitary to produce growth hormone in a natural, pulsatile pattern similar to what occurred when you were younger.

Understanding Oxytocin

How does oxytocin work for intimacy?

Sermorelin is a bioidentical synthetic peptide that consists of the first 29 amino acids of growth hormone releasing hormone (GHRH). Your pituitary gland naturally produces GHRH to signal the release of growth hormone. As we age, both GHRH and growth hormone levels decline, contributing to many signs of aging. Sermorelin mimics natural GHRH, restoring the signal that tells your pituitary to produce growth hormone in a natural, pulsatile pattern similar to what occurred when you were younger.

Combining Treatments

How do I know which treatment is right for me?

Sermorelin is a bioidentical synthetic peptide that consists of the first 29 amino acids of growth hormone releasing hormone (GHRH). Your pituitary gland naturally produces GHRH to signal the release of growth hormone. As we age, both GHRH and growth hormone levels decline, contributing to many signs of aging. Sermorelin mimics natural GHRH, restoring the signal that tells your pituitary to produce growth hormone in a natural, pulsatile pattern similar to what occurred when you were younger.

Sermorelin is a bioidentical synthetic peptide that consists of the first 29 amino acids of growth hormone releasing hormone (GHRH). Your pituitary gland naturally produces GHRH to signal the release of growth hormone. As we age, both GHRH and growth hormone levels decline, contributing to many signs of aging. Sermorelin mimics natural GHRH, restoring the signal that tells your pituitary to produce growth hormone in a natural, pulsatile pattern similar to what occurred when you were younger.

Sermorelin is a bioidentical synthetic peptide that consists of the first 29 amino acids of growth hormone releasing hormone (GHRH). Your pituitary gland naturally produces GHRH to signal the release of growth hormone. As we age, both GHRH and growth hormone levels decline, contributing to many signs of aging. Sermorelin mimics natural GHRH, restoring the signal that tells your pituitary to produce growth hormone in a natural, pulsatile pattern similar to what occurred when you were younger.

Sermorelin is a bioidentical synthetic peptide that consists of the first 29 amino acids of growth hormone releasing hormone (GHRH). Your pituitary gland naturally produces GHRH to signal the release of growth hormone. As we age, both GHRH and growth hormone levels decline, contributing to many signs of aging. Sermorelin mimics natural GHRH, restoring the signal that tells your pituitary to produce growth hormone in a natural, pulsatile pattern similar to what occurred when you were younger.

Sermorelin is a bioidentical synthetic peptide that consists of the first 29 amino acids of growth hormone releasing hormone (GHRH). Your pituitary gland naturally produces GHRH to signal the release of growth hormone. As we age, both GHRH and growth hormone levels decline, contributing to many signs of aging. Sermorelin mimics natural GHRH, restoring the signal that tells your pituitary to produce growth hormone in a natural, pulsatile pattern similar to what occurred when you were younger.

For questions not covered here, please contact your Connect Med provider. We’re here to support your hair restoration journey every step of the way.

Hormones and Sexual Health

When should I consider hormone replacement therapy instead?

Sermorelin is a bioidentical synthetic peptide that consists of the first 29 amino acids of growth hormone releasing hormone (GHRH). Your pituitary gland naturally produces GHRH to signal the release of growth hormone. As we age, both GHRH and growth hormone levels decline, contributing to many signs of aging. Sermorelin mimics natural GHRH, restoring the signal that tells your pituitary to produce growth hormone in a natural, pulsatile pattern similar to what occurred when you were younger.

Sermorelin is a bioidentical synthetic peptide that consists of the first 29 amino acids of growth hormone releasing hormone (GHRH). Your pituitary gland naturally produces GHRH to signal the release of growth hormone. As we age, both GHRH and growth hormone levels decline, contributing to many signs of aging. Sermorelin mimics natural GHRH, restoring the signal that tells your pituitary to produce growth hormone in a natural, pulsatile pattern similar to what occurred when you were younger.

Sermorelin is a bioidentical synthetic peptide that consists of the first 29 amino acids of growth hormone releasing hormone (GHRH). Your pituitary gland naturally produces GHRH to signal the release of growth hormone. As we age, both GHRH and growth hormone levels decline, contributing to many signs of aging. Sermorelin mimics natural GHRH, restoring the signal that tells your pituitary to produce growth hormone in a natural, pulsatile pattern similar to what occurred when you were younger.

For questions not covered here, please contact your Connect Med provider. We’re here to support your hair restoration journey every step of the way.

Privacy and Practical Matters

How discreet is the packaging?

Sermorelin is a bioidentical synthetic peptide that consists of the first 29 amino acids of growth hormone releasing hormone (GHRH). Your pituitary gland naturally produces GHRH to signal the release of growth hormone. As we age, both GHRH and growth hormone levels decline, contributing to many signs of aging. Sermorelin mimics natural GHRH, restoring the signal that tells your pituitary to produce growth hormone in a natural, pulsatile pattern similar to what occurred when you were younger.

Sermorelin is a bioidentical synthetic peptide that consists of the first 29 amino acids of growth hormone releasing hormone (GHRH). Your pituitary gland naturally produces GHRH to signal the release of growth hormone. As we age, both GHRH and growth hormone levels decline, contributing to many signs of aging. Sermorelin mimics natural GHRH, restoring the signal that tells your pituitary to produce growth hormone in a natural, pulsatile pattern similar to what occurred when you were younger.

Sermorelin is a bioidentical synthetic peptide that consists of the first 29 amino acids of growth hormone releasing hormone (GHRH). Your pituitary gland naturally produces GHRH to signal the release of growth hormone. As we age, both GHRH and growth hormone levels decline, contributing to many signs of aging. Sermorelin mimics natural GHRH, restoring the signal that tells your pituitary to produce growth hormone in a natural, pulsatile pattern similar to what occurred when you were younger.

Sermorelin is a bioidentical synthetic peptide that consists of the first 29 amino acids of growth hormone releasing hormone (GHRH). Your pituitary gland naturally produces GHRH to signal the release of growth hormone. As we age, both GHRH and growth hormone levels decline, contributing to many signs of aging. Sermorelin mimics natural GHRH, restoring the signal that tells your pituitary to produce growth hormone in a natural, pulsatile pattern similar to what occurred when you were younger.

Sermorelin is a bioidentical synthetic peptide that consists of the first 29 amino acids of growth hormone releasing hormone (GHRH). Your pituitary gland naturally produces GHRH to signal the release of growth hormone. As we age, both GHRH and growth hormone levels decline, contributing to many signs of aging. Sermorelin mimics natural GHRH, restoring the signal that tells your pituitary to produce growth hormone in a natural, pulsatile pattern similar to what occurred when you were younger.

For questions not covered here, please contact your Connect Med provider. We’re here to support your hair restoration journey every step of the way.